These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8051541

  • 1. Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.
    Molenda JJ, Basinger MA, Hanusa TP, Jones MM.
    J Inorg Biochem; 1994 Aug 01; 55(2):131-46. PubMed ID: 8051541
    [Abstract] [Full Text] [Related]

  • 2. Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.
    Molenda JJ, Jones MM, Johnston DS, Walker EM, Cannon DJ.
    J Med Chem; 1994 Dec 09; 37(25):4363-70. PubMed ID: 7996548
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-ones.
    Molenda JJ, Jones MM, Basinger MA.
    J Med Chem; 1994 Jan 07; 37(1):93-8. PubMed ID: 8289206
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH, Licéaga J, Arthur HM, Kontoghiorghes GJ.
    Am J Hematol; 1990 May 07; 34(1):21-5. PubMed ID: 2327400
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
    Bergeron RJ, Streiff RR, Wiegand J, Luchetta G, Creary EA, Peter HH.
    Blood; 1992 Apr 01; 79(7):1882-90. PubMed ID: 1558978
    [Abstract] [Full Text] [Related]

  • 7. A family of hydroxypyrone ligands designed and synthesized as iron chelators.
    Toso L, Crisponi G, Nurchi VM, Crespo-Alonso M, Lachowicz JI, Santos MA, Marques SM, Niclós-Gutiérrez J, González-Pérez JM, Domínguez-Martín A, Choquesillo-Lazarte D, Szewczuk Z.
    J Inorg Biochem; 2013 Oct 01; 127():220-31. PubMed ID: 23859830
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
    Kontoghiorghes GJ, Chambers S, Hoffbrand AV.
    Biochem J; 1987 Jan 01; 241(1):87-92. PubMed ID: 3566714
    [Abstract] [Full Text] [Related]

  • 9. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
    Sheppard LN, Kontoghiorghes GJ.
    Arzneimittelforschung; 1993 Jun 01; 43(6):659-63. PubMed ID: 8352819
    [Abstract] [Full Text] [Related]

  • 10. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L.
    Am J Hematol; 1993 Apr 01; 42(4):340-9. PubMed ID: 8493983
    [Abstract] [Full Text] [Related]

  • 11. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
    Kontoghiorghes GJ, Sheppard L, Chambers S.
    Arzneimittelforschung; 1987 Oct 01; 37(10):1099-102. PubMed ID: 3435580
    [Abstract] [Full Text] [Related]

  • 12. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, Barr J, Wonke B, Kourouclaris T, Sheppard L.
    Br Med J (Clin Res Ed); 1987 Dec 12; 295(6612):1509-12. PubMed ID: 3122880
    [Abstract] [Full Text] [Related]

  • 13. Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives.
    Nurchi VM, Crisponi G, Lachowicz JI, Murgia S, Pivetta T, Remelli M, Rescigno A, Niclós-Gutíerrez J, González-Pérez JM, Domínguez-Martín A, Castiñeiras A, Szewczuk Z.
    J Inorg Biochem; 2010 May 12; 104(5):560-9. PubMed ID: 20185179
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, Cillard P.
    Free Radic Biol Med; 1992 Nov 12; 13(5):499-508. PubMed ID: 1334028
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel pegylated iron chelators with decreased metabolic rate.
    Li J, Lu Z, Kong X, Ma Y, Zhang X, Bansal SS, Abbate V, Hider RC.
    Future Med Chem; 2015 Nov 12; 7(18):2439-49. PubMed ID: 26670054
    [Abstract] [Full Text] [Related]

  • 18. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
    Harrington JM, Mysore MM, Crumbliss AL.
    Dalton Trans; 2018 May 22; 47(20):6954-6964. PubMed ID: 29721567
    [Abstract] [Full Text] [Related]

  • 19. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators.
    Lachowicz JI, Nurchi VM, Crisponi G, Jaraquemada-Pelaez Mde G, Ostrowska M, Jezierska J, Gumienna-Kontecka E, Peana M, Zoroddu MA, Choquesillo-Lazarte D, Niclós-Gutiérrez J, González-Pérez JM.
    J Inorg Biochem; 2015 Oct 22; 151():94-106. PubMed ID: 26281974
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.